Real-time enrollment status for this lipoprotein disorder clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 8:28 PM UTC
| NCT Number | NCT07327840 |
| Recruiting Status | Recruiting |
| Condition | Lipoprotein Disorder |
| Phase | PHASE2 |
| Target Enrollment | 204 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Kylonova (Xiamen) Biopharma co., LTD. |
| Last Updated on CT.gov | June 25, 2026 (Jun 25, 2026) |
As of August 28, 2026: Clinical trial NCT07327840 is currently recruiting participants. This phase2 study for lipoprotein disorder is actively seeking new participants at 16 locations across the United States. The study is sponsored by Kylonova (Xiamen) Biopharma co., LTD.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07327840 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07327840 was last updated Jun 25, 2026 (June 25, 2026). HelloStudys verifies this status automatically.